The Trial Sample Clauses

POPULAR SAMPLE Copied 2 times
The Trial. 6.1 The Recipient shall conduct the Trial for the trial period as stipulated in Schedule 1 to this Agreement in accordance with the terms and conditions of this Agreement unless the Government agrees otherwise in writing. 6.2 The Recipient shall provide the particulars of the Subsidized Products including the registered owners and vehicle(s) / vessel(s) registration numbers to the Government and agree that such information will be disclosed to the relevant Government departments including without limitation to the Transport Department and Marine Department. The Government reserves the right to request for further information if deemed necessary. 6.3 The Recipient is hereby informed and also agrees that the relevant Government departments referred to in Clause 6.2 above to inform other Government departments including without limitation the Environment and Ecology Bureau (Environment Branch) whenever this is any change in the ownership of the Subsidized Product. This Clause shall survive the completion of this Agreement and shall continue in full force and effect notwithstanding such completion of this Agreement. 6.4 The Recipient shall not sell or assign the Subsidized Products which are purchased with the provision of the Subsidy in accordance with this Agreement before the completion of the trial period of the Trial as stipulated in Schedule 1 to this Agreement without the written consent of the Government. The Government may exercise the right to terminate this Agreement and be entitled to cease to pay any unpaid portions of the Subsidy to the Recipient immediately. The Government shall be entitled to require the Recipient to forthwith return to the Government all the Subsidy it has already received. 6.5 The Recipient shall not use the Subsidized Product during the trial period of the Trial as stipulated in Schedule 1 to this Agreement to fulfill the contractual obligations in, arising from or incidental to any government contract(s) which the Recipient or other party has signed or will sign with the Government. 6.6 The Recipient shall install an independent meter to record the fuel/energy consumption of each unit of charging or similar support system of Subsidized Product during the trial period of the Trial as stipulated in Schedule 1 to this Agreement. 6.7 The Recipient shall ensure that its directors, staff and agents will not offer, solicit or accept any advantage (as defined in the Prevention of Bribery Ordinance (Cap. 201)) in connection with the...
View SourceView Similar (6)
The Trial. 6.1 The Recipient shall conduct the Trial for the trial period as provided in Schedule 1 in accordance with the terms and conditions 6.2 The Recipient shall not sell or assign the Subsidized Products which are purchased with the provision of the Subsidy in accordance with this Agreement before the expiration of the trial period of the Trial without the consent of the Government. 6.3 The Recipient shall install an independent metering to record fuel/energy consumption of each unit of charging or similar support system of Subsidized Product during the trial period of the Trial. 6.4 The Recipient shall ensure that its directors, staff and agents will not offer, solicit or accept any advantage (as defined in the Prevention of Bribery Ordinance (Cap. 201)) in connection with the Trial.
View SourceView Similar (4)
The Trial. 6.1 The Recipient shall conduct the Trial for the trial period as stipulated in Schedule 1 to this Agreement in accordance with the terms and conditions of this Agreement unless the Government agrees otherwise in writing. 6.2 The Recipient shall not sell or assign the Subsidized Products which are purchased with the provision of the Subsidy in accordance with this Agreement before the completion of the trial period of the Trial as stipulated in Schedule 1 to this Agreement without the written consent of the Government. 6.3 The Recipient shall not use the Subsidized Product during the trial period of the Trial as stipulated in Schedule 1 to this Agreement to fulfill the contractual obligations in, arising from or incidental to any government contract(s) which the Recipient or other party has signed or will sign with the Government. 6.4 The Recipient shall install an independent meter to record the fuel/energy consumption of each unit of charging or similar support system of Subsidized Product during the trial period of the Trial as stipulated in Schedule 1 to this Agreement. 6.5 The Recipient shall ensure that its directors, staff and agents will not offer, solicit or accept any advantage (as defined in the Prevention of Bribery Ordinance (Cap. 201)) in connection with the Trial.
View SourceView Similar (3)
The Trial. 6.1 The Company shall supply to the Principal Investigator the Products and/or parts of the Product and/or the materials from which the Product is composed, without consideration, at the necessary pharmaceutical standard, all in accordance with the schedule and in the quantities provided in the Trial Protocol. 6.2 The Trial shall be performed and managed by the Principal Investigator at the Hospital facilities, while making use of the Hospital's resources. 6.3 The Principal Investigator shall carry out the Trial in accordance with the Trial Protocol, GCP, and all the relevant laws and regulations prevailing in Israel and in accordance with all necessary permits and/or licenses from the relevant authorities. 6.4 In performance of the Trial, the Fund shall employ, directly or indirectly, the Trial Personnel, which will comprise the individuals specified in the list appended herewith and marked as Appendix B to this Agreement. 6.5 To avoid any doubt, it is hereby clarified that the Fund and/or the Principal Investigator shall not perform any acts which deviate from the acts specified in the Trial Protocol and/or are specifically mentioned in this Agreement unless the Fund has approved said acts, in advance and in writing. 6.6 Subject to the provisions of Section 13 below, the representatives of the Company shall have the right to examine the results, notes and other documents and representations obtained during the course of the Trial, during regular working hours, after providing advanced written notice and at a reasonable time. To avoid any doubt, it is clarified that this sub-section and any provision of this Agreement shall not be deemed as providing management and/or supervision authority to the Company or to anyone on its behalf over the Trial and/or the Principal Investigator and/or whomever of the Trial Personnel. 6.7 In performance of the Trial, pursuant to this Agreement, the Company undertakes to continue to supply the Product to the Fund and/or the Hospital, without consideration, in order to complete the commenced treatment of the Participants of the Trial at the Principal Investigator’s sole and reasonable discretion, or as part of the Trial Protocol, should one of the Participants of the Trial become dependent on the Product. For avoidance of doubt, it is hereby clarified that this obligation of the Company shall remain in effect even in the event that the Agreement has been terminated or is voided for any reason, but only for so long as it sha...
View SourceView Similar (3)
The Trial. On the morning of the trial and two days after it had made a similar application by email which I had rejected, FIFA again sought an adjournment of the trial. It relied on a change in circumstances which was this. FIFA had on 24/09/2020 suspended the TTFA. It contended that as a consequence of the suspension, the Normalisation Committee was no longer in charge, there was therefore no urgency for the matter to proceed. A letter was produced which was written by FIFA on 06/10/2020 to the chairman of the Normalisation Committee which showed otherwise. It was ironical that this could be advanced as a ground for an adjournment. The suspension was engineered by FIFA. If anything it made the determination of the proceedings in my view more urgent. In response to a direct question, ▇▇. ▇▇▇▇▇-▇▇▇▇▇ was still unable to indicate that FIFA would respect any ruling of the Court. I refused the adjournment.
View SourceView Similar (2)
The Trial. The Court has not yet scheduled a trial to decide who is right in this case. ght?
View Source
The Trial. The case came to trial on 20 January 2025. At the hearing, ▇▇ ▇▇▇▇ was represented by ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ and ▇▇ ▇▇▇▇ Bin ▇▇▇▇▇ of Middle East Alliance Legal Consultancy LLC. The Defendants were represented by ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ Al-Ameri and ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇ of ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇-▇▇▇▇▇ Advocates and Legal Consultants.
View Source
The Trial. (a) The Customer will not be charged for the use of the Services during the Trial Period. (b) It shall be the responsibility of the Customer to notify Safaricom of any faults or errors in the Services during the Trial. The Customer shall notify Safaricom of any such faults or errors through the contact details set out in the Service Level Agreements. The Customer shall not be entitled to any extension of the Trial Period following any System failures during the Trial Period. (c) Unless the Customer gives Safaricom notice of the Customer’s intention to discontinue the Services prior to the expiry of the Trial Period, the Customer will be billed the Charges for the Services from the date following expiry of the Trial Period. For the avoidance of doubt, the Customer must terminate the Services before the end of the Trial Period to avoid Charges.
View Source

Related to The Trial

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • The Study 1The parties must comply with, and conduct the Study in accordance with, the Protocol and any conditions of the Reviewing HREC. In addition the parties must comply with the following, as applicable:

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Free Trial If Customer uses a Free Trial Service, PROS will make such Free Trial Service available to Customer on a trial basis, free of charge, until the earlier of (a) the end of the free trial period for which Customer agreed to use such Free Trial Service, (b) the start date of any Subscription Service purchased by Customer for the same service, or (c) termination of the Free Trial Service by PROS in its sole discretion. Additional trial terms and conditions may appear on the trial registration web page. Any such additional terms and conditions are incorporated into this Agreement by reference and are legally binding. Free Trial Services are provided for evaluation purposes and not for production use. Customer shall have sole responsibility and PROS assumes no liability for any Customer Data that Customer may choose to upload on the Free Trial Services. NOTWITHSTANDING SECTION 5 AND 6 ABOVE, FREE TRIAL SERVICES ARE PROVIDED “AS IS” WITH NO EXPRESS OR IMPLIED WARRANTY AND PROS SHALL HAVE NO INDEMNIFICATION OBLIGATIONS, NOR ANY LIABILITY OF ANY TYPE WITH RESPECT TO A FREE TRIAL SERVICE, UNLESS SUCH EXCLUSION OF LIABILITY IS UNENFORCEABLE UNDER APPLICABLE LAW IN WHICH CASE, PROS TOTAL AGGREGATE LIABILITY ARISING OUT OF OR RELATING TO A FREE TRIAL SERVICE IS US$1,000. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN SECTION 7 ABOVE, CUSTOMER SHALL BE FULLY LIABLE FOR ANY DAMAGES ARISING OUT OF ITS USE OF A FREE TRIAL SERVICE. ANY CUSTOMER DATA AND CONFIGURATIONS ENTERED INTO CUSTOMER’S FREE TRIAL SERVICE ACCOUNT MAY BE PERMANENTLY LOST UPON TERMINATION OF THE FREE TRIAL SERVICE.

  • Trial EACH OF THE PARTIES HERETO HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DEALINGS BETWEEN THE PARTIES HERETO RELATING TO THE SUBJECT MATTER HEREOF OR THEREOF. EACH OF THE PARTIES HERETO ALSO WAIVES ANY BOND OR SURETY OR SECURITY UPON SUCH BOND THAT MIGHT, BUT FOR THIS WAIVER, BE REQUIRED OF THE OTHER PARTY. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH OF THE PARTIES HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO THIS AGREEMENT, THAT EACH HAS ALREADY RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN ITS RELATED FUTURE DEALINGS. EACH OF THE PARTIES HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS RESPECTIVE LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH SUCH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THE WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT. IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.